Clinical Ketamine Practice Resources
Clinical operations, patient-selection, informed consent, outcome measures, and implementation resources for low-dose ketamine care.
Operational use
This hub supports structured clinical review, documentation, and monitoring conversations.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Featured
3 articles
Ketamine Therapy in Rural Communities: Overcoming Access Barriers
How are rural patients accessing low-dose ketamine therapy? Review of telehealth models, sublingual at-home protocols, and barriers to in-clinic care.
How to Start a Ketamine Therapy Practice: A Clinician's Guide
A comprehensive guide for clinicians on launching a ketamine therapy practice, covering DEA licensing, state regulations, clinical protocols, compounding pharmacy partnerships, liability considerations, and insurance frameworks.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
What do published low-dose ketamine case studies show? Review of clinical outcomes, dosing patterns, and lessons across depression, pain, and anxiety cases.
Ketamine Therapy in Rural Communities: Overcoming Access Barriers
How are rural patients accessing low-dose ketamine therapy? Review of telehealth models, sublingual at-home protocols, and barriers to in-clinic care.
How to Start a Ketamine Therapy Practice: A Clinician's Guide
A comprehensive guide for clinicians on launching a ketamine therapy practice, covering DEA licensing, state regulations, clinical protocols, compounding pharmacy partnerships, liability considerations, and insurance frameworks.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
What do published low-dose ketamine case studies show? Review of clinical outcomes, dosing patterns, and lessons across depression, pain, and anxiety cases.
Does Insurance Cover Ketamine Therapy?
Most insurance plans do not cover IV ketamine infusions for depression, though FDA-approved intranasal esketamine (Spravato) has broader insurance coverage.
How Much Does Ketamine Therapy Cost?
A single ketamine IV infusion typically costs between $400 and $800, with a full initial course of 6 infusions ranging from $2,400 to $4,800.
How to Prepare for Your First Ketamine Therapy Session
A comprehensive patient-oriented guide to preparing for an initial ketamine treatment session, covering what to expect, pre-treatment medical requirements, medication considerations, practical logistics, and strategies for optimizing treatment outcomes.
Cost-Effectiveness of Ketamine Therapy: Health Economic Evidence
Health economic analysis of ketamine therapy cost-effectiveness, examining direct treatment costs, comparative value versus alternatives, QALY gains, and payer perspectives.
Low-Dose Ketamine in Emergency Psychiatry: Acute Management Protocols
Review of low-dose ketamine in emergency psychiatry settings, covering acute suicidal ideation management, agitation protocols, ED implementation, and rapid assessment frameworks.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
What rules govern telehealth ketamine advertising? Review of FDA, FTC, and state guidance on marketing low-dose ketamine therapy through virtual platforms.
Measuring Ketamine Treatment Outcomes: Validated Assessment Tools
How is ketamine response actually measured? A review of validated depression scales, suicidality tools, functional assessments, and biomarkers used in trials.
Informed Consent for Ketamine Treatment: Essential Elements
Guide to informed consent for ketamine treatment, covering essential disclosure elements, off-label considerations, risk communication, and documentation best practices.
Clinically Significant Drug Interactions with Low-Dose Ketamine
Which medications interact with low-dose ketamine? Review of CNS depressants, serotonergic drugs, CYP enzyme effects, and cardiovascular medication overlap.
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
How are patients monitored during at-home low-dose ketamine sessions? Review of remote vitals, observer protocols, video check-ins, and safety frameworks.
Geriatric Considerations in Low-Dose Ketamine Therapy
Is ketamine therapy safe for elderly patients? Review of age-related pharmacokinetics, cardiovascular risk, cognitive monitoring, and low-dose adjustments.
Patient Selection Criteria for Low-Dose Ketamine Therapy
Evidence-based patient selection criteria for low-dose ketamine therapy, covering indications, contraindications, risk-benefit assessment, and clinical decision-making frameworks.